Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models

MARIA A. SMOLLE, DIMOSTHENIS ANDREOU, JUDITH WÖLFEL, IBTISSAM ACEM, MICHIEL AJ VAN DE SANDE*, L. E.E. JEYS, H. A.N. BONENKAMP, R. O.B. POLLOCK, PER E.R.U.L.F. TUNN, R. I.C.K. HAAS, FLORIAN POSCH, ROBERT J. VAN GINKEL, CORNELIS VERHOEF, BERNADETTE LIEGL-ATZWANGER, DALIA MOUSTAFA-HUBMER, PHILIPP J. JOST, ANDREAS LEITHNER, JOANNA SZKANDERA

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

11 Downloads (Pure)

Samenvatting

Background and purpose: Neoadjuvant (NRTX) and adjuvant radiotherapy (ARTX) reduce local recurrence (LR) risk in extremity soft tissue sarcoma (eSTS), yet their impact on distant metastasis (DM) and overall survival (OS) is less well defined. This study aimed at analysing the influence of NRTX/ARTX on all three endpoints using a retrospective, multicentre eSTS cohort. 

Materials and methods: 1200 patients (mean age: 60.7 ± 16.8 years; 44.4 % females) were retrospectively included, treated with limb sparing surgery and curative intent for localised, high grade (G2/3) eSTS. 194 (16.2 %), 790 (65.8 %), and 216 (18.0 %) patients had received NRTX, ARTX and no RTX, respectively. For the resulting three groups (no RTX vs. NRTX, no RTX vs. ARTX, NRTX vs. ARTX) Fine&Gray models for LR and DM, and Cox-regression models for OS were calculated, with IPTW-modelling adjusting for imbalances between groups. 

Results: In the IPTW-adjusted analysis, NRTX was associated with lower LR-risk in comparison to no RTX (SHR [subhazard ratio]: 0.236; p = 0.003), whilst no impact on DM-risk (p = 0.576) or OS (p = 1.000) was found. IPTW-weighted analysis for no RTX vs. ARTX revealed a significant positive association between ARTX and lower LR-risk (SHR: 0.479, p = 0.003), but again no impact on DM-risk (p = 0.363) or OS (p = 0.534). IPTW-weighted model for NRTX vs. ARTX showed significantly lower LR-risk for NRTX (SHR for ARTX: 3.433; p = 0.003) but no difference regarding DM-risk (p = 1.000) or OS (p = 0.639). 

Conclusion: NRTX and ARTX are associated with lower LR-risk, but do not seem to affect DM-risk or OS. NRTX may be favoured over ARTX as our results indicate better local control rates.

Originele taal-2English
Artikelnummer109944
Aantal pagina's8
TijdschriftRadiotherapy and Oncology
Volume189
DOI's
StatusPublished - dec.-2023

Citeer dit